NEW YORK–(BUSINESS WIRE) March 03, 2021 — The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for Lorbrena® (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase…
Read More
Easy-to-deliver mRNA treatment shows promise for stopping flu and COVID-19 viruses
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes COVID-19. Best of all, the treatment…
Read More
Effective treatment for insomnia delivered in a few short phone calls
Insomnia—trouble falling asleep, staying asleep or waking up too early—is a common condition in older adults. Sleeplessness can be exacerbated by osteoarthritis, the most common form of arthritis causing joint pain. While there are effective therapies for treating insomnia in…
Read More
New therapeutic target for Huntington’s treatment
Huntington’s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations. The origin of this disease has been associated with the anomalous functioning of the mutated protein mHTT,…
Read More
Cabozantinib most effective treatment for metastatic papillary kidney cancer
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer—findings expected to change medical practice. These findings will…
Read More
Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial
A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under. Results published today in Human Vaccines & Immunotherapeutics report the…
Read More
Vitamin D treatment for Covid: Boris Johnson urged to bring in ‘Andalusia’ method
Conservative backbencher David Davis MP had previously called for the UK Government to distribute vitamin D supplementation to society’s most at-risk of COVID-19. Mr Davis says Britain should follow the lead of the Spanish region of Andalusia, which distributed calcifediol, a…
Read More
Rhod gilbert health: Star on his infertility – ‘I have never spoken to anyone about it’
Male infertility: Doctor discusses likely causes Rhod Gilbert’s comedic talents have made him a mainstay of British television shows. The comedian displayed an uncharacteristically solemn side to his personality this morning on ITV’s Lorraine. The TV favourite revealed his personal…
Read More
Bone density loss from Anastrozole partially reverses after treatment stops
A study by researchers from Queen Mary University of London shows that bone loss known to be associated with the use of the breast cancer prevention drug Anastrozole partially reverses, particularly at the lumbar spine, after stopping treatment. Anastrozole is…
Read More
Artificial intelligence tool for reading MRI scans could transform prostate cancer surgery and treatment
Researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University have preliminarily validated an artificial intelligence (AI) tool to predict how likely the disease is to recur following surgical treatment for prostate cancer. The…
Read More